Cornell University is a private Ivy League and statutory land-grant research university, based in Ithaca, New York.

During the past decade, Cornell University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cornell University" #1 sponsor was "Cornell University" with 10 trials, followed by "Johns Hopkins All Children's Hospital" with 1 trials sponsored, "University of California, San Francisco" with 1 trials sponsored, "University of Cincinnati" with 1 trials sponsored and "University of Minnesota" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cornell University" #1 collaborator was "Arogyavaram Medical Centre" with 1 trials as a collaborator, "Carl Zeiss Meditec AG" with 1 trials as a collaborator, "Cornell University" with 1 trials as a collaborator, "Foodnet Meals on Wheels" with 1 trials as a collaborator and "Instituto Nacional de Salud Publica, Mexico" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cornell University" are "Mukbang" (2 trials), "Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients" (1 trials), "Anemia, Iron Deficiency" (1 trials), "Chronic Pain" (1 trials) and "Immunity" (1 trials). Many other conditions were trialed in "Cornell University" in a lesser frequency.

Most popular intervention types in "Cornell University" are "Other" (8 trials), "Behavioral" (3 trials), "Dietary Supplement" (3 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "25 mg/day Choline" (1 trials), "550 mg/day Choline" (1 trials), "Built Environment" (1 trials) and "Conventional duration (3 months) of anticoagulant therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cornell University" are 9 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Cornell University". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Cornell University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cornell University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

Cornell University has several departments that took part in Clinical trials: "Cornell Clinical Trials Unit - Chelsea Clinic" - 20 trials, "Human Metabolic Research Unit, Cornell University" - 15 trials, "Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine" - 10 trials, "Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine" - 8 trials, "Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC)" - 5 trials, "Cornell Univ Medical College; Hematology-Oncolog" - 5 trials, "Weill Cornell Cancer Center" - 3 trials, "Weill Cornell Medical College-Peds" - 2 trials, "Cornell Univ., Div. of Ped. Infectious Diseases & Immunology" - 2 trials